Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atara Biotherap (NQ: ATRA )

16.98 USD -0.11 (-0.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 696,566
Open 17.00
Bid (Size) 16.99 (1)
Ask (Size) 17.99 (3)
Prev. Close 17.09
Today's Range 16.36 - 17.43
52wk Range 11.81 - 28.20
Shares Outstanding 88,417,386
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and... 
From Business Wire News Releases
European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Tabelecleucel for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferat
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and... 
From Business Wire News Releases

Performance

YTD
-13.54%
-13.54%
1 Month
-3.74%
-3.74%
3 Month
+10.91%
+10.91%
6 Month
+20.77%
+20.77%
1 Year
-35.26%
-35.26%

More News

Read More
Atara Biotherapeutics to Participate at Three Upcoming Investor Conferences
From Business Wire News Releases
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Atara Biotherapeutics to Present Eight Abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting, Including First Presentation of Tab-cel® Pivotal Phase 3 (ALLELE) Data
From Business Wire News Releases
Atara Biotherapeutics Announces Third Quarter 2021 Financial Results and Operational Progress
From Business Wire News Releases
Atara Biotherapeutics to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021
From Business Wire News Releases
Atara Biotherapeutics Presents New Magnetization Transfer Ratio Imaging Data and Two-Year Clinical Data from the Open Label Extension of ATA188 for Progressive Multiple Sclerosis at ECTRIMS 2021
From Business Wire News Releases
How Bad Are Atara Biotherapeutics's Earnings? | Return On Capital Employed
Tags ATRA Market News BZI/ROCE
From Benzinga
Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel®)
From Business Wire News Releases
First Week of June 2022 Options Trading For Atara Biotherapeutics (ATRA)
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.